• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diffuse calcinosis and intradermal tophi in a uremic pateint: effect of low-calcium hemodialysis and mechanism of hypercalcemia.

作者信息

Hsu Sun-Chieh, Lee Yu-Yun, Wang Ming-Cheng, Liu Hsin-Liang, Cheng Meng-Fu, Huang Jeng-Jong

机构信息

Department of Emergency Medicine, National Cheng Kung University, Tainan, Taiwan (ROC).

出版信息

Blood Purif. 2004;22(2):224-8. doi: 10.1159/000076857.

DOI:10.1159/000076857
PMID:15044822
Abstract

Soft tissue calcification is a frequent complication in end-stage renal disease (ESRD) patients with a high serum calcium-phosphate product, but systemic involvement of both the visceral organs and skin is rarely seen. We report on a newly diagnosed ESRD patient with gouty nephropathy who had initial presentations of extensive intradermal tophi, diffuse calcinosis, and hypercalcemia. He received maintenance hemodialysis (HD) with low-calcium dialysate (1.25 mEq/l) for 11 months. Although the above complications diminished, serum calcium remained elevated. Thereafter, unexpected cervical lymphadenitis from a Mycobacterium tuberculosis (TB) infection with high extra-renal production of calcitriol was found. Serum calcium levels normalized only after anti-TB treatment for 2 months. We thought that this patient might have had occult TB infection before the start of HD, which resulted in calcitriol production and hypercalcemia. In addition, concomitant hyperphosphatemia in chronic renal failure contributed to severe diffuse calcinosis. After the initiation of HD therapy, both the elevated serum calcitriol levels and accelerated resolution and mobilization of diffuse calcinosis from low-calcium HD contributed to persistent hypercalcemia.

摘要

相似文献

1
Diffuse calcinosis and intradermal tophi in a uremic pateint: effect of low-calcium hemodialysis and mechanism of hypercalcemia.
Blood Purif. 2004;22(2):224-8. doi: 10.1159/000076857.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Treatment of severe metastatic calcification in hemodialysis patients.血液透析患者严重转移性钙化的治疗。
Hemodial Int. 2009 Apr;13(2):163-7. doi: 10.1111/j.1542-4758.2009.00353.x.
4
Review of dialysate calcium concentration in hemodialysis.血液透析中透析液钙浓度的综述。
Hemodial Int. 2006 Oct;10(4):326-37. doi: 10.1111/j.1542-4758.2006.00125.x.
5
Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis.一名维持性透析的结核病患者出现高钙血症和骨化三醇升高。
Arch Intern Med. 1986 Oct;146(10):1941-5.
6
Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients.腹膜透析患者使用低钙(2.5毫当量/升)和高钙(3.5毫当量/升)透析液的情况。
Adv Perit Dial. 1992;8:385-8.
7
Dialysate calcium profiling during hemodialysis: use and clinical implications.血液透析期间的透析液钙分析:应用及临床意义
Kidney Int. 2002 Jan;61(1):276-87. doi: 10.1046/j.1523-1755.2002.00100.x.
8
Successful use of zero calcium dialysate to treat hypercalcemia in a postsurgical peritoneal dialysis patient.成功使用无钙透析液治疗一名术后腹膜透析患者的高钙血症。
Adv Perit Dial. 1993;9:284-7.
9
[Posttransplant regression of uremic tumoral calcinosis].[尿毒症性肿瘤性钙化症移植后消退]
Nefrologia. 2007;27(3):378-81.
10
Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.
N Engl J Med. 1984 Dec 27;311(26):1683-5. doi: 10.1056/NEJM198412273112607.

引用本文的文献

1
Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review.接受透析的痛风患者中别嘌醇的给药方法、药代动力学及疗效:一项范围综述
J Nephrol. 2025 Mar 25. doi: 10.1007/s40620-025-02269-7.